Mark Fereshteh - Concepedia

Author

Mark Fereshteh

Bristol-Myers Squibb (United States)

Also Known As

Fereshteh, Mark P., M. Fereshteh, Mark Fereshteh, Mark P. Fereshteh, mark fereshteh

Publications

2.2K

Citations

H-Index

Concepts

All Affiliations

Bristol-Myers Squibb (United States)Biocon (India)Duke Medical Center Duke University Hospital Bristol-Myers Squibb (India)

About

Mark Fereshteh is an author at Bristol-Myers Squibb (United States) specializing in medicine, tumor biology, and cell signaling.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	1.6K
2	Cell Biology	4	4	1K
3	Health Sciences	1	1	852
4	Biochemistry	1	1	35
5	Biomolecular Engineering	1	1	37

Mark Fereshteh

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia Chen Zhao, Alan Chen, Catriona Jamieson, Nature Tumor BiologyDevelopmental BiologyMedicineHedgehog SignallingAdult Stem Cell	2009	852
Itraconazole, a Commonly Used Antifungal that Inhibits Hedgehog Pathway Activity and Cancer Growth James Kim, Jean Y. Tang, Ruoyu Gong, Cancer Cell Antifungal AgentAntifungal AgentsMedicinePathologyAntimicrobial Chemotherapy	2010	506
Preclinical Characterization and Phase I Trial Results of a Bispecific Antibody Targeting PD-L1 and 4-1BB (GEN1046) in Patients with Advanced Refractory Solid Tumors Alexander Muik, Elena Garralda, Friederike Gieseke, Cancer Discovery	2022	104
The Nuclear Receptor Coactivator Amplified in Breast Cancer-1 Is Required for <i>Neu</i> (ErbB2/HER2) Activation, Signaling, and Mammary Tumorigenesis in Mice Mark Fereshteh, Maddalena T. Tilli, Sung Eun Kim, Cancer Research	2008	96
Epidermal Growth Factor Receptor Tyrosine Phosphorylation and Signaling Controlled by a Nuclear Receptor Coactivator, Amplified in Breast Cancer 1 Tyler Lahusen, Mark Fereshteh, Annabell S. Oh, Cancer Research	2007	72
Tyrosine Phosphorylation of the Nuclear Receptor Coactivator AIB1/SRC-3 Is Enhanced by Abl Kinase and Is Required for Its Activity in Cancer Cells Annabell S. Oh, John T. Lahusen, Christopher D. Chien, Molecular and Cellular Biology Breast OncologyTyrosine KinaseBreast Cancer 1Cancer BiologyTumor Biology	2008	61
Critical role of kinase activity of hematopoietic progenitor kinase 1 in anti-tumor immune surveillance Jinqi Liu, Joshua C. Curtin, Dan You, PLoS ONE ImmunologyImmune RegulationCell DeathImmunoeditingImmune Cell Therapy	2019	57
β-Arrestin2 mediates the initiation and progression of myeloid leukemia Mark Fereshteh, Takahiro Ito, Jeffrey J. Kovacs, Proceedings of the National Academy of Sciences Hematological MalignancyCancer ResearchDevelopmental BiologyCell RegulationSignaling Pathway	2012	53
Targeted Disruption of β-Arrestin 2-Mediated Signaling Pathways by Aptamer Chimeras Leads to Inhibition of Leukemic Cell Growth Jonathan W. Kotula, Jin‐Peng Sun, Margie Li, PLoS ONE	2014	49
Antroquinonol A: Scalable Synthesis and Preclinical Biology of a Phase 2 Drug Candidate Matthew T. Villaume, Eran Sella, Garrett Saul, ACS Central Science Medicinal ChemistryNatural Product SynthesisMedicineExciting Biological PropertiesMedicinal Fungi	2015	37

Page 1